Data sets for: Iterative Safe-by-Design Development of an Antibacterial Coating: Balancing

Four novel coating formulations for prosthetic joints were assessed for safety and efficacy using Safe-by-Design principles. The dataset likely contains results from in vitro tests evaluating bacterial adhesion, osteoblast behavior, and immune response. It was authored by Agtmaal, J. and last updated on 2026-05-18.

Use Cases

• Compare the antibacterial efficacy of different polymer concentrations based on the described PEL and HA formulations.
• Analyze the relationship between coating composition and osteoblast behavior for implant biocompatibility.
• Evaluate immune response to novel biomaterials as part of a Safe-by-Design development framework.
• Model the trade-off between antibacterial efficacy and cellular safety for prosthetic joint coatings.

Strengths

• Dataset is based on a structured Safe-by-Design (SbD) development principle.
• In vitro testing covers three distinct biological endpoints: bacterial adhesion, osteoblast behavior, and immune response.
• Compares four specific coating formulations with defined concentration changes (e.g., PEL-10 to PEL-20, HA-1 to HA-5).

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for large-scale analysis.
• The description does not specify if in vivo results are included, limiting the dataset to in vitro findings.

Provenance

Source

DataverseNL Harvested Dataverse

Collection Method

Likely contains experimental results from laboratory assessments of coating formulations.

Freshness

Last updated 2026-05-18 06:13:24; freshness should be verified.